PAC Fixed Dose: Pharmacokinetics of a 1-Hour Paclitaxel Infusion and Comparison to BSA-Normalized Drug Dosing

Publisher： Karger

E-ISSN： 2296-5262|29|10|444-450

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.29, Iss.10, 2006-09, pp. : 444-450

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of 1-Hour and 3-Hours Paclitaxel Infusion Pharmacokinetics: Results from a Randomized Trial

By  

Oncology Research and Treatment, Vol. 25, Iss. 6, 2003-01 ,pp. : 503-508

Karger

Access to resources Recommend Favorite

Phase II Study of Weekly Paclitaxel and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin in the Treatment of Recurrent or Metastatic Gastric Cancer

By  

Oncology, Vol. 69, Iss. 1, 2005-09 ,pp. : 88-95

Karger

Access to resources Recommend Favorite

Paclitaxel by 72-Hour Continuous Infusion Followed by Bolus Intravenous Ifosfamide or Epirubicin: Results of Two Phase I Studies

By  

Oncology, Vol. 60, Iss. 2, 2001-02 ,pp. : 116-122

Karger

Access to resources Recommend Favorite

Pharmacokinetics of an Extended 4‐hour Infusion of Piperacillin‐Tazobactam in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 6, 2015-06 ,pp. : 600-607

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dose Escalation Study of Paclitaxel in Combination with Fixed-Dose Irinotecan in Patients with Advanced Non-Small Cell Lung Cancer (JCOG 9807)

By  

Oncology, Vol. 66, Iss. 2, 2004-05 ,pp. : 94-100

Karger

Access to resources Recommend Favorite